Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received positive feedback from the US Food and Drug...…
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, will present new data on its lead candidate POLB 001 at...…
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received a Canadian patent approval covering the use...…
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) CEO, Jeremy Skillington, talked with Proactive about recent progress alongside Principal Scientist Liam...…